SKA1 overexpression has been observed in gastric cancer, oral adenosquamous carcinoma, prostate cancer, papillary thyroid carcinoma, non-small cell lung cancer, and salivary adenoid cystic carcinoma [9–11, 22–24]. Here, SKA1 is linked to non-small cell lung carcinoma.